Cargando…

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis

Detalles Bibliográficos
Autores principales:	Kirk, Paul, Witkover, Aviva, Courtney, Alan, Lewin, Alexandra M, Wait, Robin, Stumpf, Michael P, Richardson, Sylvia, Taylor, Graham P, Bangham, Charles R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112756/ http://dx.doi.org/10.1186/1742-4690-8-S1-A43

Ejemplares similares

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kirk, Paul DW, et al.
Publicado: (2011)

NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis
por: McCormick, Matthew, et al.
Publicado: (2011)

Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2014)

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Schwalb, Alvaro, et al.
Publicado: (2020)

Balance assessment in HTLV-1 associated myelopathy or tropical spastic paraparesis
por: Patrício, Naiane Araújo, et al.
Publicado: (2020)

Ciclosporin A Proof of Concept Study in Patients with Active, Progressive HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
por: Martin, Fabiola, et al.
Publicado: (2012)

Editorial Commentary: Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) and HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
por: Taylor, Graham P.
Publicado: (2015)

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2016)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2019)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Rafatpanah, Houshang, et al.
Publicado: (2013)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

Proteomic profiling of HTLV-1 infected T-cells for the identification of potential biomarkers and therapeutic targets for HTLV-1 associated myelopathy/ tropical spastic paraparesis and adult T-cell leukemia
por: Ueda, Koji, et al.
Publicado: (2011)

Contribution of Galvanic Vestibular Stimulation for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Matos Cunha, Luciana Cristina, et al.
Publicado: (2013)

Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity
por: Sato, Tomoo, et al.
Publicado: (2018)

Impact of fractures and orthopedic surgeries in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis
por: Julca-Copello, Pablo, et al.
Publicado: (2020)

Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Yamakawa, Natsuko, et al.
Publicado: (2020)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2017)

Patterns of spinal cord atrophy in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP)
por: Charlip, Emily, et al.
Publicado: (2015)

Novel Complications with HTLV‐1‐associated Myelopathy/Tropical Spastic Paraparesis: Interstitial Cystitis and Persistent Prostatitis
por: Nomata, Koichiro, et al.
Publicado: (1992)

Genome wide association study of HTLV-1–associated myelopathy/tropical spastic paraparesis in the Japanese population
por: Penova, Marina, et al.
Publicado: (2021)

Impaired flexibility in patients with tropical spastic paraparesis/HTLV-associated myelopathy: evaluation via pendulum fleximeter
por: Landim, Caroline, et al.
Publicado: (2023)

Changes in proviral load (PVL) among patients with rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) receiving empirical therapy
por: Gotuzzo, Eduardo, et al.
Publicado: (2011)

Visualization of HTLV-1–Specific Cytotoxic T Lymphocytes in the Spinal Cords of Patients With HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
por: Matsuura, Eiji, et al.
Publicado: (2015)

Immunopathogenesis of Human T-Cell Leukemia Virus Type-1-Associated Myelopathy/Tropical Spastic Paraparesis: Recent Perspectives
por: Saito, Mineki, et al.
Publicado: (2012)

CXCL10 and neopterin in CSF are candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Yamano, Yoshihisa, et al.
Publicado: (2014)

Biomarker to predict treatment response in patients with HTLV-1 associated myelopathy/Tropical spastic paraparesis (HAM/TSP)
por: Tamaki, Keiko, et al.
Publicado: (2015)

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
por: Tsutsumi, Shuntaro, et al.
Publicado: (2019)

Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1–associated myelopathy/tropical spastic paraparesis
por: Nagasaka, Misako, et al.
Publicado: (2020)

Pregnancy complicated by HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP): a case report
por: Mori, Hiroshi, et al.
Publicado: (2021)

Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Baratella, Marco, et al.
Publicado: (2017)

Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2020)

Quantifying spinal cord cross-sectional area in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Liu, Winston, et al.
Publicado: (2014)

INTERFERON BETA-1A TREATMENT IN HTLV-1-ASSOCIATED MYELOPATHY/TROPICAL SPASTIC PARAPARESIS: A CASE REPORT
por: Viana, Graça Maria de Castro, et al.
Publicado: (2014)

Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Saito, Mineki, et al.
Publicado: (2013)

Clinical presentation of axial myopathy in two siblings with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Matsuura, Eiji, et al.
Publicado: (2015)

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene
por: Vallinoto, Antonio C. R., et al.
Publicado: (2015)

Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients
por: Queiroz, Gabriel Andrade Nonato, et al.
Publicado: (2019)

Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Tamaki, Keiko, et al.
Publicado: (2019)

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL)
por: Zarei-Ghobadi, Mohadeseh, et al.
Publicado: (2021)

Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon
por: Takatani, Massanobu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9btnqdaqa4g4sn5jg83povbf7b